International Patent: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF ANGIOPOIETIN-LIKE 4 (ANGPTL4)

GENEVA, Oct. 22 -- SHANGHAI ARGO BIOPHARMACEUTICAL CO., LTD. filed a patent application (CN2026/091223) for “COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF ANGIOPOIETIN-LIKE 4 (ANGPTL4)”. With publication no. WO/2026/219328, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/113

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....